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Abstract Toxoplasma gondii deploys many effector proteins in order to hijack and 25 
manipulate host cell signalling pathways, allowing parasite colonization, subversion of 26 
immune responses and disease progression. T. gondii effector protein 14-3-3 (Tg14-3-3) 27 
promotes parasite dissemination inside the body, by enhancing the migratory ability of 28 
infected microglia and dendritic cells. Understanding both the mechanism of action, and the 29 
host targets of Tg14-3-3 effector is important because of their importance to the parasite’s 30 
virulence. The aim of the present study was to explore the function of Tg14-3-3 by utilizing 31 
the yeast two hybrid system (Y2HS) to identify novel Tg14-3-3 interactors/substrates in host 32 
cells. A human cDNA library was screened using Tg14-3-3 as the bait. Tg14-3-3 (RH strain, 33 
Type I) was cloned into the pGBKT7 vector and expressed in the Y2HGold yeast strain. The 34 
bait protein expression was validated by Western blotting analysis, auto-activation and 35 
toxicity investigation compared with control (Y2HGold yeast strain transformed with empty 36 
pGBKT7 vector). Two positive Tg14-3-3 interactors identified by this screening, 37 
hCG1821272 and eIF5B (Eukaryotic translation initiation factor 5B), were isolated and 38 
characterized. This approach made it possible to gain a better understanding of the function of 39 
Tg14-3-3 in regulating host proteins involved in key cellular processes, such as translational 40 
initiation and cell migration. 41 
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Introduction 53 
 54 
It is estimated that more than one-third of the human population are chronically infected with 55 
Toxoplasma gondii (Montoya and Liesenfeld 2004). This parasite is highly adapted to survive 56 
in a variety of microenvironments. On reaching and penetrating the brain the parasite forms a 57 
lifelong infection, encysting in a latent state (bradyzoite) for decades from which it is 58 
periodically activated via lysis to a fulminant infection (Elsheikha 2008). Global healthcare 59 
challenges from this parasite are increasing due to a paucity of human vaccines; while 60 
currently available drugs are often toxic and have limited clinical efficacy (Katlama et al. 61 
1996), especially against the latent phase of disease.  62 
Obligatory intracellular apicomplexan protozoan parasites, such as T. gondii cause 63 
disease by reiterating their lytic cycle of, host cell invasion, parasite replication, and parasite 64 
egress. These parasites are rapidly motile within the body, and succeed in invading and 65 
colonizing the host cells through the spatiotemporal deployment of a diverse range of effector 66 
proteins (secretome) released by unique secretory organelles (micronemes and rhoptries). This 67 
secretome is required for host cell invasion, and plays critical roles in hijacking cellular 68 
processes and reprogramming the host cell signaling pathways to enable pathogen survival 69 
and proliferation. For example, proteins in the rhoptry neck (RONs) are initially secreted into 70 
the host cell membrane, where they help mediate the formation of a moving junction 71 
composed of RON2, RON4 and RON5 together with the micronemal protein AMA1. Kinase 72 
proteins in the bulb of the rhoptry (ROPs) are then released into the host cell cytosol to 73 
perturb various host cell processes (Saffer et al. 1992; Saeij et al. 2006; Taylor et al. 2006; 74 
Sibley et al. 2009), where they are directed to the host cell nucleus (e.g., ROP16 and protein 75 
phosphatase 2C (PP2C-hn)) or to the surface of the parasitophorous vacuole (PV) (e.g., 76 
ROP2, ROP18 and ROP5).  77 
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Protein secretion is key to parasite survival, promoting virulence and allowing T. gondii 78 
to detect and respond to its host environment. In eukaryotic cells, the 14-3-3 family of 79 
proteins are critical regulators of key proteins involved in various physiological processes, 80 
such as apoptosis (Nomura et al. 2003), cell migration (Kobayashi et al. 2011) and 81 
cytoskeleton remodeling (Sluchanko and Gusev 2010). These 14-3-3 proteins have been 82 
identified in some apicomplexan protozoans, including Eimeria tenella, Neospora caninum, 83 
Plasmodium falciparum and T. gondii (Siles-Lucas Mdel and Gottstein 2003). Toxoplasma 84 
gondii effector protein 14-3-3 (known as Tg14-3-3) can induce hyper-migration of parasitized 85 
microglia and dendritic cells (Weidner et al. 2016), suggesting that Tg14-3-3 may play a role 86 
in the parasite’s dissemination to the target host tissues. Results of 14-3-3 gene deletion 87 
studies in mammalian and yeast cells (Cognetti et al. 2002; Freeman and Morrison 2011), 88 
suggest that knockout of Tg14-3-3 gene produces non-viable T. gondii (Weidner et al. 2016). 89 
Tg14-3-3 has been considered an important vaccine candidate (Meng et al. 2012). Despite its 90 
importance in parasite dissemination within the body (Weidner et al. 2016), the host proteins 91 
that interact with Tg14-3-3 to regulate this phenomenon remain unknown. 92 
In order to better understand the roles of Tg14-3-3 in molecular host interactions, and 93 
define T. gondii effectors and molecular mechanisms involved in T. gondii pathogenesis, the 94 
objective of the present study was to identify the novel host partners interacting with 95 
Tg14-3-3 using the yeast two hybrid system (Y2HS). 96 
 97 
Materials and methods 98 
 99 
Parasites culture 100 
 101 
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Type I T. gondii RH strain was maintained in vitro by serial passage on human foreskin 102 
fibroblast (HFF) monolayers at 37°C in 5% CO2. HFF cells were grown in Dulbecco’s 103 
modified Eagle’s medium (DMEM, Gibco, USA) supplemented with 10% fetal bovine serum 104 
(FBS, Gibco, USA), and 1% antibiotics (penicillin-streptomycin solution). When about 90% 105 
of infected HFF cells were lysed, the parasites and cells were harvested and centrifuged. The 106 
mixture was washed with phosphate buffered saline (PBS) and passed through 25-gauge 107 
syringe needles. To reducing the cell debris, the tachyzoites were filtered through 3 µm 108 
membrane filters (Millipore, USA), and stored at –80 ℃. 109 
 110 
Construction of the bait vector  111 
 112 
Total RNA was isolated from T. gondii tachyzoites using TRIzol (Invitrogen, USA) following 113 
the manufacturer’s instructions. RNA yields and integrity were evaluated by 114 
spectrophotometry (NanoDrop Technologies, USA) and gel electrophoresis, respectively. 115 
Total RNA was reverse-transcribed into cDNA using the PrimeScriptⅡ1st Strand cDNA 116 
Synthesis Kit (Takara, Japan), according to the manufacturer’s instruction. To construct the 117 
Tg14-3-3 bait vector, the Tg14-3-3 gene encoding a 266 residue peptide (from 58 aa to 323 118 
aa) (Fig. 1A) was amplified from T. gondii cDNA (Fig. 1B) using the specific primers 119 
14-3-3-EcoRⅠ-1F (5′-GAATTCATGGCGGAGGAAATCAAG-3′) and 14-3-3-BamHⅠ-2R 120 
(5′-GGATCCTTACTGATCAGCTTGTTCTG-3′). The amplified 14-3-3 fragment (~801 bp) 121 
was cloned into pMD19-T (Takara, Japan), and digested with the restriction enzymes EcoRⅠ 122 
and BamHⅠ(Fig. 1B). Finally, the purified fragment was ligated into pGBKT7 (designated as 123 
pGBKT7-Tg14-3-3), and verified by restriction digestion and sequencing.  124 
 125 
Expression of the bait protein in yeast  126 
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 127 
To investigate Tg14-3-3 expression in the Y2HGold yeast strain, the pGBKT7-Tg14-3-3 was 128 
transformed into the yeast by the lithium acetate method following the manufacture’s 129 
instruction in Yeast Transformation System 2 Kit (Takara, Japan). The transformants were 130 
spread and incubated on plates containing Minimal SD Agar Base (Clontech, USA), 131 
supplemented with -Trp DO supplement (Clontech, USA) (SD/-Trp) for 3-5 days. One clone 132 
was chosen from the SD/-Trp plate and inoculated into yeast culture medium until the OD600 133 
reached 0.5. The proteins were extracted from the cell pellet using the TCA method detailed 134 
in the Clontech yeast protocol handbook (http://www.clontech.com). The extracted proteins 135 
were separated using SDS-PAGE and detected by Western immunoblotting using mouse 136 
anti-Myc primary antibody (CST, USA) and goat anti-mouse IgG-HRP secondary antibody 137 
(Santa Cruza Technologies, USA). The blot was observed with the ChemiDoc™ MP Imaging 138 
System (Bio-Rad, USA) using the ECL chemiluminescent substrate (Millipore, USA). 139 
 140 
Evaluation of toxicity and auto-activation 141 
 142 
It was important to examine if the fusion protein had initiated the transcription of the reporter 143 
gene by itself. The yeast transformants described above were plated on minimal synthetically 144 
defined (SD) medium without tryptophan (SD/-Trp), SD/-Trp medium supplemented with 145 
X-α-Gal (SD/-Trp/X-α-Gal) or SD/-Trp/X-α-Gal supplemented with Aureobasidin A (AbA, 146 
Clontech, USA) (SD/-Trp/X-α-Gal/AbA) until colonies appeared (~3-5 days). A comparison 147 
with the colonies transformed with pGBKT7 empty vector, made it easy to distinguish if the 148 
bait plasmid had induced toxicity and auto-activation. Absence of toxicity of the bait plasmid 149 
was indicated by the comparable size and appearance of the colonies to those of the pGBKT7 150 
control group. Lack of auto-activation of the bait protein was indicated by white colonies on 151 
7	  
	  
SD/-Trp and absence of blue colonies on the SD/-Trp/X-α-Gal plates and absence of colony 152 
growth on the SD/-Trp/X-α-Gal/AbA plates. The yeast two-hybrid screen was performed only 153 
when the bait protein showed no toxicity nor auto-activation. 154 
 155 
Yeast Two-Hybrid System (Y2HS) screening 156 
 157 
To screen the host proteins that interact with the Tg14-3-3 protein, the Y2HGold transformed 158 
with bait vector was mated with the Universal Human cDNA library (Clontech, USA) at 30 159 
℃ for 24 h. The mated cells were then checked, and spread on the 150 mm double dropout 160 
medium SD/-Leu/-Trp, supplemented with X-α-Gal and Aureobasidin A 161 
(DDO/X-α-Gal/AbA) to be incubated for 3-5 days. The blue colonies (potential positives) 162 
were picked from DDO/X-α-Gal/AbA agar plates and re-streaked onto quadruple dropout 163 
medium SD/-Ade/-His/-Leu/-Trp, supplemented with X-α-Gal and Aureobasidin A 164 
(QDO/X-α-Gal/AbA). To eliminate the duplicate clones, yeast colony PCR was performed 165 
and the products were analyzed by electrophoresis. The prey plasmids were extracted from 166 
potential positives by Easy Yeast Plasmid Isolation Kit (Clontech, USA) and transformed into 167 
E. coli DH5α competent cells, followed by selecting on LB/Amp plates.  In order to confirm 168 
any positive interaction, a point-to-point yeast mating was applied to exclude false positive 169 
hits. Briefly, each extracted prey plasmid was transformed into the Y187 strain, which was 170 
mated with the Y2HGold transformed with pGBKT7-Tg14-3-3. Mated yeast groups were 171 
then spread onto the QDO/X-α-Gal/AbA plates to test for interactions. True positive hits were 172 
indicated by blue colonies under these conditions. 173 
 174 
Analysis of the positive preys 175 
 176 
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When the interaction was confirmed as positive, the insert sequence of the prey plasmid was 177 
sequenced by the T7 sequencing primer. We ensured that the open reading frame was fused in 178 
frame to the GAL4 transcriptional activation domain. The insert sequence of the positive 179 
preys was subjected to BLAST search (https://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify the 180 
corresponding human genes, followed by Gene Ontology (GO) analysis.  181 
 182 
Results and discussion  183 
 184 
   In this study, the pGBKT7-Tg14-3-3 bait vector containing the conserved 14-3-3 region 185 
(66 aa-308 aa) was constructed (Fig. 1) and transformed into yeast strain Y2HGold. In order 186 
to detect the Tg14-3-3 protein expression, total proteins of Y2HGold cells were extracted and 187 
examined by immunoblotting assay using the Myc-tag (9B11) mouse mAb (Cell Signaling). 188 
The relative molecular weight of the Tg14-3-3 fusion protein was determined to be 56 kD 189 
(Fig. 2A, lane 1), and as a control, the GAL4 DNA-binding domain protein, which was 190 
extracted as above was approximately 21 kD (Fig. 2A, lane 2). Then we investigated whether 191 
the bait had autonomously activated (autoactivated) the reporter genes in yeast stain Y2HGold 192 
in the absence of a prey protein. The pGBKT7-Tg14-3-3 had no toxicity to yeast, when 193 
compared with the colony size and shape of the pGBKT7 control group (Fig. 2B).  194 
To identify putative host proteins that specifically interact with Tg14-3-3, we screened a 195 
human cDNA library using the Y2HS. Over 50 colonies were grown on the plates, six of 196 
which turned blue and the inserts were amplified by prey primers (T7 primer and 3′AD primer; 197 
Fig. 3A, P1-P6). Finally, zygotes containing the prey vector (Fig. 3A, P3 or P4) and 198 
pGBKT7-Tg14-3-3 appeared blue on the QDO/X-α-Gal/AbA (Fig. 3B, 1 or 2), but zygotes 199 
harboring the prey vector (P3 or P4) and pGBKT7 did not (Fig. 3B, C1 or C2). These results 200 
indicate that the two prey vectors (P3 and P4) specifically interacted with the 201 
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pGBKT7-Tg14-3-3. To determine the host gene identity, BLAST analysis showed that these 202 
two inserts (Fig. 3A, P3 and P4) shared high similarity (99-100%) to the human gene 203 
hCG1821272 (EAW77836.1) and to the Homo sapiens eukaryotic translation initiation factor 204 
5B (HseIF5B; BC032639.1), respectively. Gene Ontology (GO) analysis showed that 205 
hCG1821272 as a hypothetical, non-annotated protein, whereas HseIF5B is mainly involved 206 
in translational initiation.  207 
Eukaryotic initiation factor 5 subunit B (eIF5B) is the eukaryotic ortholog of the bacterial 208 
IF2 initiation factor and is one of two essential GTPases required for ribosomal subunit 209 
joining during translation initiation (Acker et al. 2006; Aitken and Lorsch et al. 2012; Kuhle 210 
and Ficner 2014; Nag et al. 2016). Relevant to the present study is the ability of eIF5B to 211 
enhance the proliferation and metastasis of hepatocellular carcinoma cells via upregulation of 212 
ASAP1, a protein involved in regulation of membrane trafficking and cytoskeleton 213 
remodeling (Wang et al. 2016). It is likely that the enhanced migratory ability of T. 214 
gondii-infected immune cells is mediated through Tg14-3-3-eIF5B interaction. 14-3-3 215 
proteins are known to act by binding to partner proteins, often leading to altered subcellular 216 
localization of the binding partner proteins (Muslin and Xing 2000). Additional experiments 217 
measuring Tg14-3-3 influence specifically on eIF5B localization may fully characterize the 218 
outcome of this interaction in the host. Further investigation into the consequences on 219 
hyper-migration of host infected cells should be pursued in order to determine whether the 220 
identified interaction represents the most crucial host target by Tg14-3-3 or if other targets are 221 
more pertinent to virulence. 222 
The Y2HS has been successfully applied to study protein-protein interactions in T. gondii 223 
(Ahn et al. 2006; Kim et al. 2008; Cheng et al. 2012; Wang et al. 2014) and has provided new 224 
insight into the interaction between important parasite proteins and host signaling pathways. 225 
However, due to the limitations of this method (i.e. the necessity for the bait-prey interaction 226 
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to occur in the cell nucleus for the reporter gene to be activated, the presence of negative 227 
positives and the lack of the ability to screen components in situ), and the use of the truncated 228 
peptide rather than the full-length of Tg14-3-3, it is likely that the spectrum of host interactors 229 
with Tg14-3-3 has not been fully defined. It could be argued that fewer positives were 230 
detected because Tg14-3-3 is localized within the parasitophorous vacuolar space (Assossou 231 
et al. 2003; Assossou et al. 2004; Weidner et al. 2016). However, Tg14-3-3 protein has 232 
already produced a positive interaction with two host proteins. It is also possible that 233 
Tg14-3-3 may have a GRA14-like unique topology in the parasitophorous vacuole membrane 234 
(PVM), with the C terminus facing the host cytoplasm and N terminus facing the 235 
parasitophorous vacuolar lumen (Rome et al. 2008). Recently developed technologies, such as 236 
proximity-­‐dependent biotin identification (BioID), which uses a promiscuous bacterial biotin 237 
ligase to detect protein-protein associations and proximate proteins in living cells, and to label 238 
proteins in subcellular compartments in T. gondii (Chen et al. 2015; Nadipuram et al. 2016), 239 
may circumvent some of the limitations associated with the Y2HS to investigate how T. 240 
gondii effector proteins, localized to non-nuclear compartments, can regulate cellular 241 
processes inside the parasitized host cells. 242 
In conclusion, the present study identified two new host interacting proteins, eIF5B and 243 
hCG1821272, that are involved in many important biological processes. These findings enrich 244 
the previously discovered array of interactions that occur between T. gondii effectors and host 245 
proteins. The identified interaction between Tg14-3-3 and the two host proteins merits further 246 
investigations to fully characterize the regulatory mechanisms by which Tg14-3-3 regulates 247 
its target host proteins. Such studies will unmask urgently needed novel therapeutic targets.  248 
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 351 
 352 
 353 
 354 
Fig. 1. Construction of the Tg14-3-3 bait plasmid. (A) Schematic illustration of the full-length 355 
Tg14-3-3 and the truncated region of Tg14-3-3 used in the yeast two hybrid screening. (B) 356 
Lane1: gel electrophoresis analysis of the region of Tg14-3-3 amplified from T. gondii cDNA; 357 
Lane 2: the pGBKT7-Tg14-3-3 vector was confirmed by digestion with EcoRⅠ and 358 
BamHⅠ. Lane M: DL 5000 molecular marker.  359 
 360 
 361 
 362 
 363 
 364 
 365 
 366 
 367 
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 368 
 369 
 370 
 371 
Fig. 2. Expression and autoactivation of Tg14-3-3 in Y2HGold cells. (A) Western blotting 372 
detection of the bait vector expression in Y2HGold cells. Lane 1: pGBKT7-Tg14-3-3 vector; 373 
Lane 2: pGBKT7 empty vector. (B) Determination of autoactivation and toxicity of the bait 374 
vector in Y2HGold cells on different selection plates.   375 
 376 
 377 
 378 
 379 
 380 
 381 
 382 
 383 
 384 
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 385 
Fig. 3. Analysis of putative positives. (A) Detecting PCR products amplified from putative 386 
positives. Lane P1-P6: PCR products amplified from the putative positives P1-P6 (responding 387 
to prey vectors P1-P6); Lane M: DL 5000 marker. (B) Confirmation of putative positives. 388 
Y2HGold cells transformed with bait vector were mated with Y187 containing each of prey 389 
vectors (P1-P6), respectively. Zygotes were grown on QDO/X-α-Gal/AbA plates. Zygotes 390 
containing pGBKT7-53 and pGADT7-T were used as positive controls (Fig. 3B, PC), and 391 
zygotes containing pGBKT7 and pGADT7-T were used as negative controls (Fig. 3B, NC). 392 
Zygotes containing pGBKT7-Tg14-3-3 and pGADT7-P3/P4 are shown in Fig. 3B, 1/2; 393 
zygotes containing pGBKT7 and pGADT7-P3/P4 are shown in Fig. 3B, C1/C2. 394 
 395 
